Cleared Traditional

K833900 - BACTROL TB SLIDE (FDA 510(k) Clearance)

K833900 · Difco Laboratories, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1983
Decision
38d
Days
-
Risk

K833900 is an FDA 510(k) clearance for the BACTROL TB SLIDE.

Submitted by Difco Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on December 22, 1983 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Difco Laboratories, Inc. devices

Submission Details

510(k) Number K833900 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 1983
Decision Date December 22, 1983
Days to Decision 38 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 77d · This submission: 38d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -